Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features — Shenghua Gao (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features
Shared by
De Clercq Erik
KU Leuven
Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features
Article
2022
en
Authors
+10 more
SG
Shenghua Gao
YC
Yusen Cheng
SS
Shu Song
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2021
Chemical space exploration of novel naphthyl-carboxamide-diarylpyrimidine derivatives with potent anti-HIV-1 activity
Ya-Li Sang
,
Christophe Pannecouque
,
De Clercq Erik
,
Chunlin Zhuang
,
Fen‐Er Chen
Article
2009
Sulfanyltriazole/tetrazoles: A Promising Class of HIV-1 NNRTIs
Peng Zhan
,
Zhenyu Li
,
Xinyong Liu
,
De Clercq Erik
Article
1995
Oxathiin Carboxanilide Derivatives: A Class of Non-Nucleoside HIV-1-Specific Reverse Transcriptase Inhibitors (NNRTIs) that are Active against Mutant HIV-1 Strains Resistant to other NNRTIs
Jan Balzarini
,
Heidi Jonckheere
,
WilliamO. Harrison
,
D.C. Dao
,
Jozef Anné
,
De Clercq Erik
,
Anna Karlsson
Article
2017
Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored “hydrophobic channel”
Zhongxia Zhou
,
Tao Liu
,
Dongwei Kang
,
Zhipeng Huo
,
Gaochan Wu
,
Dirk Daelemans
,
De Clercq Erik
,
Christophe Pannecouque
,
Peng Zhan
,
Xinyong Liu
Article
2019
Discovery of novel indolylarylsulfones as potent HIV-1 NNRTIs via structure-guided scaffold morphing
Tong Zhao
,
Qing Meng
,
Dongwei Kang
,
Jianbo Ji
,
De Clercq Erik
,
Christophe Pannecouque
,
Xinyong Liu
,
Peng Zhan
Discussion(0)
No comments yet. Be the first to comment.